Lung cancer,breast cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ?Adult patients with unresectable locally advanced or metastatic lung cancer or breast cancer confirmed by histopathological and/or cytological examination; ?AJCC stage of III or IV; ?Confirmed with at least one measurable lesion by CT or MRI according to RECIST 1.1 criteria for assessing the objective efficacy of tumor treatment; ?Assessed by NRS2002 The presence of nutritional risk or PG-SGA assessment of malnutrition; ? no serious important organ comorbidities; ? complete and reliable clinical history information
Exclusion criteria
Exclusion criteria: ?Patients with double or multiple primary malignancies; ?Patients without pathological confirmation; ?Patients with severe cardiac, hepatic or renal dysfunction or other life-threatening comorbidities; ?Patients with incomplete clinical data
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall Survival;Progression-free Surviva;survival rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Objective Response Rate;Disease Control Rate;body mass;body mass index;total protein;prealbumin;albumin;adverse reaction rate;Severity of adverse reactions; | — |
Countries
China
Contacts
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, China.